163 related articles for article (PubMed ID: 35548450)
1. Pathway-Based Analysis Revealed the Role of Keap1-Nrf2 Pathway and PI3K-Akt Pathway in Chinese Esophageal Squamous Cell Carcinoma Patients With Definitive Chemoradiotherapy.
Dai H; Wei Y; Liu Y; Liu J; Yu R; Zhang J; Pang J; Shao Y; Li Q; Yang Z
Front Genet; 2021; 12():799663. PubMed ID: 35548450
[TBL] [Abstract][Full Text] [Related]
2. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy.
Li L; Sun J; Liu N; Yu R; Zhang J; Pang J; Ou Q; Yin Y; Cui J; Yao X; Zhao R; Shao Y; Yuan S; Yu J
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):382-394. PubMed ID: 36167753
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy.
Feng A; Yang N; Yu R; Liu J; Pang J; Wu X; Shao Y; Yang Z; Dai H
Onco Targets Ther; 2022; 15():41-51. PubMed ID: 35046666
[TBL] [Abstract][Full Text] [Related]
6. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
Wang Z; Zhang J; Li M; Kong L; Yu J
Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
[TBL] [Abstract][Full Text] [Related]
7. A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma.
Huang R; Dai Q; Yang R; Duan Y; Zhao Q; Haybaeck J; Yang Z
Front Oncol; 2022; 12():817916. PubMed ID: 35574327
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
[TBL] [Abstract][Full Text] [Related]
9. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
[TBL] [Abstract][Full Text] [Related]
11. Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study.
Jo YY; Yu J; Song KJ; Jang JY; Yoo YJ; Kim SB; Park SR; Kim YH; Kim HR; Kim JH
Radiother Oncol; 2021 Sep; 162():112-118. PubMed ID: 34265356
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
[TBL] [Abstract][Full Text] [Related]
13. Favorable versus unfavorable prognostic groups by post-chemoradiation FDG-PET imaging in node-positive esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.
Yap WK; Chang YC; Hsieh CH; Chao YK; Chen CC; Shih MC; Hung TM
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):689-698. PubMed ID: 29188300
[TBL] [Abstract][Full Text] [Related]
14. Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy.
Chi D; Chen B; Guo S; Bai K; Ma H; Hu Y; Li Q; Zhu Y
Aging (Albany NY); 2021 Mar; 13(6):8408-8420. PubMed ID: 33713398
[TBL] [Abstract][Full Text] [Related]
15. Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma.
Chen HS; Lin CH; Wu SC; Wang BY
Ann Surg Oncol; 2022 Jun; 29(6):3617-3627. PubMed ID: 34994899
[TBL] [Abstract][Full Text] [Related]
16. Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy.
Okamoto H; Fujishima F; Kamei T; Nakamura Y; Ozawa Y; Miyata G; Nakano T; Katsura K; Abe S; Taniyama Y; Sakurai T; Teshima J; Hikage M; Sasano H; Ohuchi N
BMC Cancer; 2015 Mar; 15():208. PubMed ID: 25880782
[TBL] [Abstract][Full Text] [Related]
17. Analysis of clinical outcomes and prognostic factors in patients treated with definitive chemoradiotherapy for oesophageal squamous cell carcinoma.
Jeong H; Im HS; Bang Y; Kim YH; Kim HR; Lee HJ; Jung HY; Lee GH; Song HJ; Kim DH; Choi KD; Lee JH; Ahn JY; Na HK; Ryu JS; Kang J; Kim SB; Kim JH; Park SR
Cancer Med; 2021 Mar; 10(5):1745-1758. PubMed ID: 33590710
[TBL] [Abstract][Full Text] [Related]
18. A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy.
Wang P; Yang M; Wang X; Zhao Z; Li M; Yu J
Ann Transl Med; 2021 Feb; 9(3):233. PubMed ID: 33708860
[TBL] [Abstract][Full Text] [Related]
19. Molecular characteristics and multivariate survival analysis of 43 patients with locally advanced or metastatic esophageal squamous cell carcinoma.
Zhou X; Bao W; Zhu X; Wang D; Zeng P; Xia G; Xing M; Zhan Y; Yan J; Yuan M; Zhao Q
J Thorac Dis; 2024 Mar; 16(3):1843-1853. PubMed ID: 38617776
[TBL] [Abstract][Full Text] [Related]
20. The KEAP1-NRF2 System and Esophageal Cancer.
Hirose W; Oshikiri H; Taguchi K; Yamamoto M
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
